These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25239691

  • 21. Dabigatran for stroke prevention in atrial fibrillation.
    Hohnloser SH, Diener HC.
    Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
    [Abstract] [Full Text] [Related]

  • 22. Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
    Dempfle CE, Hennerici MG.
    Cerebrovasc Dis; 2011; 32(6):616-9. PubMed ID: 22133643
    [No Abstract] [Full Text] [Related]

  • 23. Thrombolysis in ischemic stroke patients on treatment with Dabigatran.
    Re G, Toni D.
    Intern Emerg Med; 2013 Aug; 8(5):451-2. PubMed ID: 23389386
    [No Abstract] [Full Text] [Related]

  • 24. Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data.
    Hernandez I, Zhang Y.
    JAMA Intern Med; 2015 Jul; 175(7):1245-7. PubMed ID: 26146922
    [No Abstract] [Full Text] [Related]

  • 25. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 26. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Sep 03; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 27. Bleeding in Patients of African Ancestry Using Dabigatran: A Potential Effect of Creatine Kinase.
    Horjus DL, van Montfrans GA, Brewster LM.
    JAMA Intern Med; 2015 Jul 03; 175(7):1243. PubMed ID: 26146917
    [No Abstract] [Full Text] [Related]

  • 28. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 03; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 29. One-Year Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation: Placing Real-World Results Into Perspective.
    Miyares MA.
    JAMA Intern Med; 2015 Jul 03; 175(7):1242-3. PubMed ID: 26146916
    [No Abstract] [Full Text] [Related]

  • 30. A Methodological Appraisal of Recent Real-World Data Publications on Dabigatran.
    Zint K, Kreuzer J.
    JAMA Intern Med; 2015 Jul 03; 175(7):1244. PubMed ID: 26146919
    [No Abstract] [Full Text] [Related]

  • 31. Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
    Hayashi H, Kitoh K, Mitsunami K, Horie M.
    Intern Med; 2012 Jul 03; 51(15):1987-90. PubMed ID: 22864123
    [Abstract] [Full Text] [Related]

  • 32. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Edwards DB, Silverberg J.
    Ann Intern Med; 2011 Apr 19; 154(8):570; author reply 570-1. PubMed ID: 21502658
    [No Abstract] [Full Text] [Related]

  • 33. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Testai FD.
    J Stroke Cerebrovasc Dis; 2013 Aug 19; 22(6):894. PubMed ID: 22868184
    [No Abstract] [Full Text] [Related]

  • 34. [Advantages of NOAKs validated in clinical routine].
    Ameri AA.
    MMW Fortschr Med; 2015 May 13; 157(9):70. PubMed ID: 26012835
    [No Abstract] [Full Text] [Related]

  • 35. Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.
    Lobo R, McCann C, Hussaini A, Meany TB, Kiernan TJ.
    Ir Med J; 2014 May 13; 107(10):329-30. PubMed ID: 25551903
    [Abstract] [Full Text] [Related]

  • 36. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC, Marrone AC.
    Cerebrovasc Dis; 2012 May 13; 34(3):246-7. PubMed ID: 23018342
    [No Abstract] [Full Text] [Related]

  • 37. A case of dabigatran-associated acute renal failure.
    Shafi ST, Negrete H, Roy P, Julius CJ, Sarac E.
    WMJ; 2013 Aug 13; 112(4):173-5; quiz 176. PubMed ID: 24734407
    [Abstract] [Full Text] [Related]

  • 38. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Jan 13; 92(1):46-53. PubMed ID: 24265137
    [Abstract] [Full Text] [Related]

  • 39. Intracranial hemorrhage during dabigatran treatment.
    Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y.
    Circ J; 2014 Jan 13; 78(6):1335-41. PubMed ID: 24662438
    [Abstract] [Full Text] [Related]

  • 40. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.